The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients.

Riccardo LeviLeonardo UbaldiChiara PozziGiovanni AngelottiMaria Teresa SandriElena AzzoliniMichela SalvaticiVictor SavevskiAlberto Mantovani Maria Rescigno

Published in: Communications medicine (2021)

SARS-CoV-2 infection induces a long lasting antibody response that increases in the first months, particularly in individuals with anosmia/dysgeusia. This may be linked to the lingering of SARS-CoV-2 in the olfactory bulb.

Keyphrases

sars cov
respiratory syndrome coronavirus
end stage renal disease
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes